PEP005 topical ingenol mebutate gel: Phase IIb start

This month, Peplin plans to start a double-blind, placebo-controlled, international Phase IIb (PEP005-015) trial to evaluate PEP005 gel applied once daily for 2 or 3 consecutive days in 240 patients w...